Anaemia in cancer: pathophysiology and treatment
- 1 August 2000
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 26 (4) , 303-311
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- What are cancer patients willing to pay for prophylactic epoetin alfa?Cancer, 1998
- 796 Prevention of chemotherapy related anemia by recombinant human erythropoietin (EPO) in patients with small cell lung cancer (SCLC) receiving cyclophosphamide, doxorubicin, and etoposide (CAE) chemotherapy with G-SCF supportLung Cancer, 1997
- Fibrinolytic inhibitors for cancer-associated bleeding problemsJournal of Pain and Symptom Management, 1997
- Use of red blood cell transfusions in terminally ill cancer patients admitted to a palliative care unitJournal of Pain and Symptom Management, 1996
- Prevention of chemotherapy‐induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double‐blind, randomized, phase III study)Transfusion, 1996
- Blood transfusion and its benefits in palliative carePalliative Medicine, 1995
- Management of bleeding in advanced cancer - a flow diagramPalliative Medicine, 1992
- Inappropriate increase in erythropoietin titers during chemotherapyAmerican Journal of Hematology, 1989
- Is There an Optimal Hemoglobin Level?Transfusion Medicine Reviews, 1989
- Transfusion-Induced Immunologic UnresponsivenessTransfusion Medicine Reviews, 1988